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Abstract
Four groups of experimental mice are studied in this experiment following
intentional exposure to murine norovirus (MNV). Two groups are exposed to the
virus at different points in their lives, and the other two are not infected and
studied alongside the other groups as controls.
Past research has indicated that B and T immune cells are not essential to
MNV resistance2. Additionally, antibody production against MNV has shown to be
slow as infection progresses1. Thus, the expected results from the experiment
are that the mice with longer infections of MNV will have larger quantities of IgG
than those more recently infected with the virus. Immunological data gathered
from these groups is compared to IgG counts from control mice, which are
comprised of pathologically clean mice of the same strain as the sentinel mice
infected with MNV and the same strain as the colony with innate exposure to
MNV.

Introduction
Murine norovirus (MNV) is the most common pathogenic species found in
laboratory mice. An RNA, non-enveloped virus, MNV is of the family Caliciviridae
and is transmitted from host to host via the fecal-oral route. Though the virus is
typically asymptomatic in mice with competent immune systems, it has caused
more detrimental pathology in mice with immunodeficiencies, particularly mice
with damaged or lost STAT1 genes, which encode proteins that respond to
interferon stimulation, particularly interferon-gamma (IFN-γ), a critical component
to development of innate and adaptive immunity6. Mice with deficiencies in
STAT1 genes that are infected with the virus have symptoms including wasting
and death. This lead to the assumption that STAT1 genes are crucial in MNV
defense in mice1,2. Less severe infections have shown inflammation in the liver,
lungs and peritoneal cavities3.
Interest in the virus has been limited due to its noninvasive nature with
research, and thus little literature is found on MNV. However, investigators with
an interest in studying immunology using murine models may have their results
questioned if their mice are infected with MNV. Those studying mice with
knocked-out or knocked-down STAT1 genes may also have difficulty in their
experiment if the colonies used are infected with the virus. It is for these reasons
and the fact that the virus is so prevalent that the experiment chose to focus on
mice colonies infected with MNV.
The experiment detailed in this report is a case study of two different
groups of mice housed in The University of Akron Research Vivarium (UARV).
The key focus was the relationship between length of infection of MNV and the
immunological results, showcased in this experiment as Immunoglobulin G (IgG)
counts of infected mice. IgG counts were chosen as the dependent variable
because of the nature of antibody count, or IgG count, increasing during viral
infection.
One group of mice, which represent a colony with historically positive
serology test results for MNV, are assumed to have been exposed to the virus
since birth, yet innate immunities have prevented any symptoms from evolving.
The other group are sentinel mice that are exposed to the virus after being
introduced into the colony from an external, MNV-negative source, and thus are
infected well after birth. Two other groups act as controls, in that neither are
exposed to MNV and have never received positive serology test results for MNV.
Past research has indicated that B and T immune cells are not essential to
MNV resistance2. Additionally, antibody production against MNV has shown to be
slow as infection progresses1. Thus, the expected results from the experiment
are that the mice with longer infections of MNV will have larger quantities of IgG
than those more recently infected with the virus. Immunological data gathered
from these groups is compared to IgG counts from control mice, which are
comprised of pathologically clean mice of the same strain as the sentinel mice
infected with MNV and the same strain as the colony with innate exposure to
MNV.

Methods
The experiment focused on 4 experimental groups. Group 1 (n=3) was
composed of sentinel mice intentionally exposed to soiled bedding and feces
from Group 2. Group 2 (n=2) included mice representing the colony with
historically positive serology tests for MNV. Group 3 (n=3) included sentinel mice
not exposed to MNV, yet exposed to feces from Group 4. Group 4 (n=2) included
control mice with historically MNV-negative serology test results.
Group 2 (1 female and 1 male, strain C57BL6) mice were bred in-house.
Group 4 (female, strain C57BL6) were imported from The Jackson Laboratory in
Sacramento, California. Sentinel mice, which were used in experimental Groups
1 and 3 are female, strain CF-1 and originate from Charles River Laboratories in
Raleigh, North Carolina.
The experiment performed was completed in tandem with the sentinel
testing program at the UARV, which was approved by the Institutional Animal
Care and Use Committee (IACUC) at The University of Akron under protocol 133C.
Mice in Group 1 were housed with a colony of mice with a history of MNV
infection, showcased by positive results following serology tests. During weekly
cage changes, dirty bedding containing fecal material from each cage in the
colony was placed in Group 1’s cage, allowing for transmission of any pathogens
present in the colony. This procedure was performed for Group 3, with the
exception that these mice were housed with a colony with historically clean
serology test results. Groups 2 and 4 were donated from the colony with MNV
and the clean colony, respectively.
Sentinel mice were housed with the colonies of experimental mice for a
period of eight weeks, allowing enough time for transmission of any present
pathogens. At the end of the eight weeks, the sentinel mice and the groups
representing the colonies the sentinels were housed with were euthanized and
serology samples were collected.
Prior to euthanasia, mice in each group were anesthetized
intraperitoneally with a combination of ketamine (75-125 mL/kg) and
acepromazine maleate (2.5-4 mL/kg) in a volume of approximately 0.1-0.25 mL
per 100 g of body weight. The ketamine and acepromazine maleate were
distributed from Vedco, Inc. and Boehringer Ingelheim Vetmedica, Inc.,
respectively, from St. Joseph, Missouri.
Blood draws, anesthesia, and euthanasia were completed for each group
using a 1-mL syringe and 25-gauge, 5/8-inch long needles vended from BectonDickinson. Blood was collected via cardiac puncture and placed into a BectonDickinson vacutainer serum tube, each group having its own tube. The serum
tube contained an clot-activator additive and was coated with silicon on the
interior. Blood from each mice belonging to the group was placed in the tube to
properly represent all in the experimental group. All mice were euthanized via an
overdose of pentobarbital-containing euthanasia solution Beuthanasia-D Special
(390 mg/mL), distributed by Schering-Plough Animal Health in Union, New
Jersey. Euthanasia was given at a minimum dose of 100-125 mg/kg. Death was

confirmed by lack of respiration and heartbeat. Following death, a gross
necropsy was performed on each mouse to observe for any anomalies. Anal
tapes, fecal floats, and cage swabs were performed to test for any presence of
ecto- and/or endoparasites. Anal tapes and fecal floats were performed in-house.
Cage swabs were sent to IDEXX BioResearch and analyzed via PCR.
The blood in each vacutainer tube was separated into serum and plasma
components via a Speedfuge Centrifuge HSC10K made by Savant Instruments,
Inc. from Farmingdale, New York. Serum from each tube was collected using a
microliter pipette and placed inside four individual Eppendorf microcentrifuge
tubes for each group. The serum samples were sent to IDEXX BioResearch in
Columbia, Missouri, where serology tests were performed to test for antibodies
against common pathogens in laboratory mice colonies. In addition to the Basic
Serology examination, IDEXX BioResearch also provided immunoglobulin counts
(µg/mL) for each serum sample.
Results
Detection of MNV by IDEXX BioResearch was completed via Multiplex
Fluorescent Immunoassay (MFI). A MNV antigen created by IDEXX was tagged
with fluorescent beads to identify presence of IgG antibodies against the virus.
Intensity of fluorescence was calculated for each treatment group in the
experiment if MNV was present in the serum.
According to the Basic Serology results from IDEXX, Group 1 tested
positive for MNV infection and Groups 2-4 tested negative (Table 1). Group 1
showed MFI (median fluorescent intensity) values of 14,500 – 15,499 for MNV,
high above the baseline for detection (MFI > 2.000). No MFI values were
reported for any other group.
Group 2 showed the highest number of IgG in the serum collected from
the members (1,907 µg/mL). Group 1 had the second highest number at 1,114
µg/mL). Groups 3 and 4 had the lowest immunoglobulin counts, at 757 µg/mL
and 812 µg/mL respectively. Results from the t-test showed that the differences
in values are statistically significant (p-value = 0.011). A graph exhibiting the IgG
counts can be found in Figure 1.
No significant findings of abnormal physiological detail, clinical health
concerns, or ectoparasites were found upon gross necropsy. Anal tapes, fecal
floats and cage swabs showed no evidence of parasitic infection. Basic Serology
results from IDEXX displayed no pathogenic species, other than MNV, had
infected the mice from Groups 1-4.

MNV
MNV Purified
Virus
MNV VP1
Recombinant

Baseline
MFI >
2.000
MFI >
3.750

Group 1
+15

Group 2
--

Group 3
--

Group 4
--

+18

--

--

--

Table 1. Detection of MNV was completed by MFI. Fluorescence was detected in Group 1
mice with a value between 14,500 – 15,499 MFI. Recombinant viruses were detected as well
at a value between 17,500 – 18,499 MFI. MNV was not detected in any other treatment
group in the experiment. Table adapted from IDEXX BioResearch Case 2423-2016.
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Figure 1. Graph shows immunoglobulin counts between Groups 1-4. Serum used per
group was a collection of blood donated by each member of the group, so counts are
aggregates. Group 2 had the highest number of IgG, followed by Group 1, 4 and 3. T-test
showed relationship between treatment group and IgG count is statistically significant (pvalue = 0.011449). Raw data supplied by IDEXX BioResearch.

Discussion
The purpose of the experiment was to observe the effects of progression
of MNV infection on the immunology of mice. Groups 1 and 2 were the key focus,
as they differed in length of exposure to the virus, with Group 2 having the virus
since birth and Group 1 being exposed to it around 6 weeks of age. Groups 3
and 4 acted as controls, as neither group was exposed to MNV or had any
history of pathogenic infection. The expected result of the case study was that
mice immediately exposed to the virus after birth (Group 2) were going to have
higher IgG counts than mice exposed to it after being introduced into the colony
(Group 1).
The results from the experiment showed that the hypothesis held true:
Group 2 had a higher immunoglobulin count (1,907 µg/mL) than Group 1 (1,114
µg/mL). Exact measurements are shown in the results and a bar graph exhibiting
the relationships between IgG counts between groups are shown in Figure 1.
However, serology test results showed that Group 2 tested negative for MNV

infection (Table 1), a possibility not initially considered prior to experimentation.
The colony that Group 2 was donated from had previously tested positive for
MNV, yet this fact shows that even though the virus is present in the colony, it
does not necessarily mean all mice are infected. This explains the results from
the serology test.
However, this calls into question the results seen in the IgG counts. Group
1’s serum contained antibodies against MNV, which would explain the higher IgG
counts when compared to mice of the same strain in Group 3, which were not
exposed to the virus. Group 2 had higher IgG counts than mice of the same
strain not infected with MNV in Group 4. Group 2 had higher numbers of
antibodies in their serum than Group 1, the only group infected with MNV.
Experimental error could have caused the results seen in the experiment.
For example, MNV antibodies could have been present in Group 2’s serum
sample but at too low of concentrations to be detected by MFI. Excluding the
possibility of experimental error, higher IgG counts in Group 2 mice could have
been diet-induced.
C57BL6 mice are highly susceptible to diet-induced obesity, a trait known
to cause higher levels of serum IgG4. In an experiment conducted by Mohammed
N. et al. in 2012, strain C57BL6 mice fed a high-fat diet, when compared to mice
with normal and low-fat diets, had more antibodies present in their serum. The
IgG targeted specific pathogenic strains of common gut bacteria, including
Escherichia coli5.
The mice in Group 2 were fed high-fat diets prior to being donated to
encourage breeding behavior. The diet caused the dam and sire to become
obese, which, given the results of Mohammed N. et al.’s experiment, may have
explained why their IgG counts were elevated, even more so than mice infected
with MNV. Group 4, the same strain as Group 2, was fed a diet containing normal
quantities of fat and results in Figure 1 show that, relatively speaking, its IgG
numbers were low. Thus, it is possible that prolonged consumption of high-fat
food and subsequent obesity causes more of an immune response than MNV
infection.
The fact that healthy B and T cells do not have as much as an effect on
fighting MNV infection as STAT1 genes might also explain why Group 1 did not
produce as much IgG. Additionally, if Group 2’s obesity caused an increase in
harmful species of gut bacteria, multiple IgG’s targeted against multiple antigens
created by these bacteria could easily explain heightened IgG levels in blood
serum. Group 1, while having MNV, was not fed a high-fat diet and therefore
could have not been hosts for associated pathogenic bacterial species, thus no
antibodies were produced.
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